Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KLA
KLAC
|
+$355M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$304M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$267M |
| 4 |
Gilead Sciences
GILD
|
+$239M |
| 5 |
Visa
V
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$388M |
| 2 |
Wells Fargo
WFC
|
+$370M |
| 3 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$295M |
| 4 |
Alibaba
BABA
|
+$234M |
| 5 |
IBM
IBM
|
+$210M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.55% |
| 2 | Healthcare | 5.29% |
| 3 | Financials | 4.23% |
| 4 | Communication Services | 3.53% |
| 5 | Energy | 2.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Highwoods Properties
HIW
$3.47B
| $3.51M | 0.01% |
74,686
-6,269
| -8% | -$273K |
|
1427
Sunstone Hotel Investors
SHO
$2.06B
| $3.51M | 0.01% |
250,731
+16,432
| +7% | +$202K |
|
1428
CALL
CME Group
CME
$94.8B
| $3.5M | 0.01% |
36,500
+12,300
| +51% | +$1.12M |
|
1429
Howard Hughes
HHH
$4.03B
| $3.5M | 0.01% |
34,962
+33,755
| +2,797% | +$3.1M |
|
1430
CALL
Martin Marietta Materials
MLM
$33B
| $3.5M | 0.01% |
22,000
+5,400
| +33% | +$742K |
|
|
ABMD
1431
DELISTED
Abiomed Inc
ABMD
| $3.49M | 0.01% |
37,099
-13,576
| -27% | -$1.15M |
|
1432
CALL
Alaska Air
ALK
$5.58B
| $3.48M | 0.01% |
42,500
+6,000
| +16% | +$443K |
|
|
EXCU
1433
DELISTED
Exelon Corporation
EXCU
| $3.48M | 0.01% |
71,029
-15,685
| -18% | -$699K |
|
|
HBI
1434
DELISTED
Hanesbrands
HBI
| $3.48M | 0.01% |
124,208
-27,138
| -18% | -$776K |
|
1435
Cooper-Standard Automotive
CPS
$558M
| $3.47M | 0.01% |
48,921
+29,821
| +156% | +$2.12M |
|
1436
Genpact
G
$5.76B
| $3.47M | 0.01% |
128,504
-3,155
| -2% | -$79.9K |
|
|
WW
1437
DELISTED
WW International
WW
| $3.47M | 0.01% |
247,689
-62,929
| -20% | -$855K |
|
1438
Carlisle Companies
CSL
$15.4B
| $3.47M | 0.01% |
35,028
+20,266
| +137% | +$1.79M |
|
1439
United Therapeutics
UTHR
$23.1B
| $3.47M | 0.01% |
31,232
+26,238
| +525% | +$3.32M |
|
1440
CALL
Royal Caribbean
RCL
$85.6B
| $3.45M | 0.01% |
42,100
+9,000
| +27% | +$702K |
|
1441
SEI Investments
SEIC
$12.6B
| $3.45M | 0.01% |
80,226
-21,382
| -21% | -$877K |
|
|
CLR
1442
PUT
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $3.45M | 0.01% |
115,000
+29,200
| +34% | +$660K |
|
1443
Douglas Emmett
DEI
$1.96B
| $3.44M | 0.01% |
114,806
-2,093
| -2% | -$59.3K |
|
1444
Core Laboratories
CLB
$521M
| $3.44M | 0.01% |
30,721
-8,100
| -21% | -$842K |
|
|
INVX
1445
Innovex International
INVX
$1.97B
| $3.44M | 0.01% |
57,343
+38,603
| +206% | +$2.15M |
|
|
OIL
1446
DELISTED
iPath Pure Beta Crude Oil ETN
OIL
| $3.44M | 0.01% |
+245,400
| New | +$3.29M |
|
|
TRCO
1447
DELISTED
TRIBUNE MEDIA COMPANY CLASS A
TRCO
| $3.43M | 0.01% |
90,309
+83,402
| +1,207% | +$2.81M |
|
1448
CALL
W.W. Grainger
GWW
$60.2B
| $3.42M | 0.01% |
14,700
+11,700
| +390% | +$2.45M |
|
1449
EQT Corp
EQT
$32.3B
| $3.41M | 0.01% |
93,456
-15,028
| -14% | -$481K |
|
1450
Range Resources
RRC
$8.95B
| $3.4M | 0.01% |
106,373
-80,253
| -43% | -$2.23M |
|
Similar funds
Barclays's Q1 2016 Portfolio in Review
As of Q1 2016, Barclays held 6,944 positions worth $65.6B, down 20% from $82.3B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Barclays withdrew a net $15.2B in Q1 2016, closing 588 positions and reducing 2,924 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $295M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.5% of assets, up from 4.9% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in State Street SPDR S&P Pharmaceuticals ETF worth $26M.
- Barclays's largest Q1 2016 buy was State Street SPDR S&P Pharmaceuticals ETF: 650,000 shares worth $26M.
- Barclays added most to KLA in Q1 2016, an estimated $355M increase.
- Barclays's biggest Q1 2016 reduction was Apple, cutting an estimated $388M.
- Barclays fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $295M.
- Barclays's ten largest holdings make up 29% of its $65.6B portfolio in Q1 2016.
- Barclays opened 766 new positions and closed 588 in Q1 2016.
- Barclays's portfolio value fell 20% quarter-over-quarter to $65.6B.
Based on Barclays's 13F filing for Q1 2016, filed 16 May 2016.